×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CATX – perspective therapeutics, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CATX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/21
07:15 am
catx
Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-a-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium
High
Report
Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-a-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium
11/15
04:08 pm
catx
Perspective Therapeutics to Discuss Data on [212Pb]VMT-a-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024
High
Report
Perspective Therapeutics to Discuss Data on [212Pb]VMT-a-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024
11/12
04:05 pm
catx
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 3Q 2024 Results
Medium
Report
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 3Q 2024 Results
10/31
07:00 am
catx
Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial Results
Low
Report
Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial Results
10/29
07:00 am
catx
Perspective Therapeutics to Participate in Upcoming Investor Conferences in November
Low
Report
Perspective Therapeutics to Participate in Upcoming Investor Conferences in November
10/24
10:09 am
catx
Perspective Therapeutics, Inc. (NYSE: CATX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $20.00 price target on the stock.
Low
Report
Perspective Therapeutics, Inc. (NYSE: CATX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $20.00 price target on the stock.
10/24
07:16 am
catx
Perspective Therapeutics, Inc. (NYSE: CATX) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $20.00 price target on the stock.
Low
Report
Perspective Therapeutics, Inc. (NYSE: CATX) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $20.00 price target on the stock.
10/23
07:00 am
catx
Perspective Therapeutics Presents Updates at the 37th Annual Congress of the European Association of Nuclear Medicine
Medium
Report
Perspective Therapeutics Presents Updates at the 37th Annual Congress of the European Association of Nuclear Medicine
Date
Time
Symbol
Company Name
Action
%Chg
11/12/2024
04:05 pm
catx
perspective therapeutics, inc.
IN-LINE
Report
-7.0%
perspective therapeutics, inc.
8/12/2024
04:05 pm
catx
perspective therapeutics, inc.
BEAT
Report
5.7%
perspective therapeutics, inc.
8/12/2024
04:05 pm
catx
perspective therapeutics, inc.
BEAT
Report
5.7%
perspective therapeutics, inc.
8/12/2024
04:05 pm
catx
perspective therapeutics, inc.
BEAT
Report
15.7%
perspective therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/21
07:31 am
catx
Form 8-K Perspective Therapeutics For: Nov 21
High
Report
Form 8-K Perspective Therapeutics For: Nov 21
11/15
07:33 am
catx
Form 8-K Perspective Therapeutics For: Nov 15
High
Report
Form 8-K Perspective Therapeutics For: Nov 15
11/14
06:15 pm
catx
Form SC 13G Perspective Therapeutics Filed by: Avidity Partners Management LP
High
Report
Form SC 13G Perspective Therapeutics Filed by: Avidity Partners Management LP
11/14
04:06 pm
catx
Form SC 13G/A Perspective Therapeutics Filed by: COMMODORE CAPITAL LP
High
Report
Form SC 13G/A Perspective Therapeutics Filed by: COMMODORE CAPITAL LP
11/14
10:24 am
catx
Form SC 13G Perspective Therapeutics Filed by: JANUS HENDERSON GROUP PLC
Low
Report
Form SC 13G Perspective Therapeutics Filed by: JANUS HENDERSON GROUP PLC
11/12
04:13 pm
catx
Form 10-Q Perspective Therapeutics For: Sep 30
Medium
Report
Form 10-Q Perspective Therapeutics For: Sep 30
11/12
04:07 pm
catx
Form 8-K Perspective Therapeutics For: Nov 12
Medium
Report
Form 8-K Perspective Therapeutics For: Nov 12
11/8
02:19 pm
catx
Form SC 13G Perspective Therapeutics Filed by: BlackRock, Inc.
Low
Report
Form SC 13G Perspective Therapeutics Filed by: BlackRock, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: